Related Experiment Video
Updated: Apr 24, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.5K
Effective interventions to improve medication adherence in Type 2 diabetes: a systematic review
Joni L Strom Williams1, Rebekah J Walker2, Brittany L Smalls1
1Center for Health Disparities Research, Medical University of South Carolina, Charleston, SC, USA ; Division of General Internal Medicine & Geriatrics, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
Diabetes Management (London, England)
|September 13, 2014
Summary
Identifying effective medication adherence interventions for Type 2 diabetes is challenging due to study design variability. Future research should focus on tailored strategies for better patient outcomes.
Area of Science:
- Endocrinology
- Pharmacology
- Public Health
Background:
- Medication adherence significantly impacts diabetes management and patient outcomes.
- While various interventions exist to improve adherence, their effectiveness in Type 2 diabetes is not well-defined.
Purpose of the Study:
- To evaluate the effectiveness of interventions aimed at improving medication adherence in adults with Type 2 diabetes.
- To identify gaps and future research directions in this field.
Main Methods:
- A systematic literature search was conducted on Medline for studies published between January 2000 and May 2013.
- Inclusion criteria focused on interventions measuring medication adherence in adult Type 2 diabetes patients.
Main Results:
- Twenty-seven studies met the inclusion criteria.
- Thirteen of these studies reported a statistically significant improvement in medication adherence.
Conclusions:
- Significant heterogeneity in study designs and adherence measures complicates the identification of universally effective interventions.
- Medication adherence alone may not be sufficient for optimal glycemic control; tailored interventions and clear adherence indicators are needed.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:28Drug Therapy
442
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
442
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
984
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
984
01:22Diabetes Mellitus: Type 2 and Gestational
4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.3K
01:16Insulin: Dosing Regimen and Adverse Effects
1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K